ClinVar Miner

Submissions for variant NM_003491.4(NAA10):c.10C>G (p.Arg4Gly)

dbSNP: rs2148537151
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Labcorp Genetics (formerly Invitae), Labcorp RCV001884103 SCV002153418 likely pathogenic not provided 2022-04-11 criteria provided, single submitter clinical testing This variant is not present in population databases (gnomAD no frequency). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. This missense change has been observed in individual(s) with clinical features of Ogden syndrome (Invitae). In at least one individual the variant was observed to be de novo. This sequence change replaces arginine, which is basic and polar, with glycine, which is neutral and non-polar, at codon 4 of the NAA10 protein (p.Arg4Gly).
Revvity Omics, Revvity RCV001884103 SCV003811012 uncertain significance not provided 2020-08-21 criteria provided, single submitter clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.